Tevogen Bio Holdings Q4 2025 Earnings NarrowerthanExpected Loss Fails to Lift Shares XOM Q1 2026 Earnings Solid EPS Beat of 143 Despite Flat Revenue Environment OOMA Q1 2026 Earnings EPS Surpasses Estimates by 929 Alto Ingredients Inc ALTO Q1 2026 Earnings Surprise Profit on Strong Cost Management and Improved Margins HMY Q2 2016 Earnings Disappointing EPS Miss Sends Shares Lower DBI Q1 2026 Earnings EPS Surprise Amid Persistent Retail Challenges